Blue Jet Healthcare Limited (BLUEJET.NS)
INR 723.25
(1.7%)
INR 723.25
(1.7%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 10.58 Billion INR | 22.83% |
| 2022 | 8.62 Billion INR | 20.84% |
| 2021 | 7.13 Billion INR | 33.02% |
| 2020 | 5.36 Billion INR | 42.86% |
| 2019 | 3.75 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 11.81 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 10.58 Billion INR | 22.83% |
| 2023 Q1 | 9.03 Billion INR | 4.84% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 9.63 Billion INR | 6.61% |
| 2023 Q4 | 10.58 Billion INR | 0.0% |
| 2022 Q1 | 7.31 Billion INR | 0.0% |
| 2022 Q4 | 8.62 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Biocon Limited | 560.7 Billion INR | 98.112% |
| Concord Biotech Limited | 17 Billion INR | 37.741% |
| Dishman Carbogen Amcis Limited | 95.81 Billion INR | 88.949% |
| Jubilant Ingrevia Limited | 47.31 Billion INR | 77.623% |
| Lyka Labs Limited | 1.56 Billion INR | -575.611% |
| Panacea Biotec Limited | 12.4 Billion INR | 14.656% |
| Piramal Pharma Limited | 153.11 Billion INR | 93.085% |
| SMS Lifesciences India Limited | 3.9 Billion INR | -171.138% |
| Supriya Lifescience Limited | 9.21 Billion INR | -14.937% |
| Syngene International Limited | 61.51 Billion INR | 82.787% |
| TAKE Solutions Limited | 881.05 Million INR | -1101.801% |
| Zota Health Care Limited | 2.28 Billion INR | -363.738% |